The Food and Drug Administration (FDA) has cleared the Essilor Stellest eyeglass lenses to slow the progression of myopia, with or without astigmatism, in children aged 6 to 12 years at the initiation ...

Potassium additives may be beneficial for patients at low risk for hyperkalemia, while phosphorus additives offer no health benefits.

HealthDay News — Targeted wrist cooling may offer a safe approach for managing vasomotor symptoms, according to a study published online September 20 in Endocrinology and Diabetes.

The Food and Drug Administration (FDA) has approved Palsonify ™ (paltusotine) for the treatment of adults with acromegaly who had an inadequate response to surgery and/or for whom surgery is not an ...

The Food and Drug Administration (FDA) has expanded the approval of Evkeeza ® (evinacumab-dgnb) to include children aged 1 year and older with homozygous familial hypercholesterolemia (HoFH).

HealthDay News — The first clinical practice guidelines on assessment and management of diabetes distress among adults were presented at the annual meeting of the European Association for the Study of ...

The CDC recommends changes to MMRV vaccine use; Trump administration claims acetaminophen linked to autism; first Barth syndrome treatment gets green light; gene therapy looks promising for Huntington ...

HealthDay News — Psilocybin-assisted therapy (PAT) shows long-term safety and efficacy for treating symptoms of major depressive disorder (MDD), according to a study published online September 4 in ...

HealthDay News — During August 2021 to August 2023, only 36.4% of US adults had no cardiovascular disease (CVD) risk factors, according to a September data brief published by the National Center for ...

Since its approval, there have been no cases of torsades de pointes or unexplained sudden death among US patients treated with Caprelsa.

Trastuzumab deruxtecan is a HER2-directed antibody and topoisomerase inhibitor conjugate currently marketed under the brand name Enhertu as a second-line therapy for HER2-positive metastatic breast ...

Up to 32% lower risk conferred by early initiation, while increased risk for dementia seen in studies among older women.